Akums Drugs And Pharmaceuticals Limited

Akums Drugs And Pharmaceuticals Limited


Akums Drugs and Pharma has raised Rs.828.78 crore from anchor investors in advance of its public IPO.

Indian pharmaceuticals manufacturer Akums Drugs and Pharmaceuticals Limited has allocated 1.22 crore equity shares at Rs.679 per share to anchor investors, according to an exchange filing. Through this anchor round, the company raised Rs.828.78 crore.


According to a filing on the Bombay Stock Exchange (BSE), Akums Drugs and Pharmaceuticals Limited announced that it raised nearly Rs.828.78 crore from anchor investors ahead of its initial public offering on Tuesday, July 30. The pharmaceutical manufacturing company allocated 1.22 crore equity shares at Rs.679 per share to its anchor investors on Monday, July 29.


Among the top anchor allocations for the share issue in the anchor round on Monday were SBI Healthcare Opportunities Fund, SBI Conservative Hybrid Fund, International Growth and Income Fund, Smallcap World Fund, Abu Dhabi Investment Authority, DSP India Fund, IIFL Asset Management Limited, BlackRock Emerging Frontiers Master Fund Limited, and BlackRock Global Funds - India Fund.


According to the filing, out of the total 1.22 crore equity shares allocated to anchor investors, 41,75,208 shares (41.75 lakh), or 34.21 percent, were allotted to domestic mutual funds that applied through 24 schemes.


SBI Healthcare Opportunities Fund and SBI Conservative Hybrid Fund received the largest equity share allocations, at 7.84 percent and 11.09 percent, respectively.


The book runners for the public issue are ICICI Securities Limited, Axis Capital Limited, Citigroup Global Market India Private Limited, and Ambit Private Limited.


Details of Akums Drugs and Pharmaceuticals IPO:


The pharmaceutical company will open for public subscription on Tuesday, July 30, and close on Thursday, August 1. The price band for the public issue has been set at Rs.646 to Rs.679 per equity share, with a face value of Rs.2 per share.


The company has set the lot size at 22 equity shares and multiples thereof. The funds raised from the public issue will be used to settle the debts of Akums Drugs and its subsidiaries. Additionally, the company plans to allocate funds towards working capital requirements and growth initiatives. Akums Drugs and Pharmaceuticals Limited is expected to list on the exchanges on August 6.

Posted on : 30-07-2024

Attention Investor

KYC IPO NSE/BSE Mobile
Sukesh Jain Securities Pvt. Ltd. (Member NSE, BSE & CDSL)

BSE Member ID: 6571

NSE Member ID:90327
SEBI Registration No.: INZ000233631
CDSL DP ID: 12080800
SEBI Registration No.: IN-DP-50-2015

Sukesh Jain Commodities Pvt. Ltd.

Sukesh Jain Capital Services Pvt.Ltd


Bank details for fund transfer:-

Sukesh Jain Securities Private Ltd.

IDBI Bank,Rajpur Road,Dehradun

Account No. 0070103000001519

IFSC:- IBKL0000070

HDFC Bank,Rajpur Road,Dehradun

57500001389543

IFSC:- HDFC0000225

Attention Investors

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. Continuation Sheet

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

6. Beware of fixed/guaranteed/regular returns/ capital protection schemes. Brokers or their authorized persons or any of their associates are not authorized to offer fixed/guaranteed/regular returns/ capital protection on your investment or authorized to enter into any loan agreement with you to pay interest on the funds offered by you. Please note that in case of default of a member claim for funds or securities given to the broker under any arrangement/ agreement of indicative return will not be accepted by the relevant Committee of the Exchange as per the approved norms.

7. Do not keep funds idle with the Stock Broker. Please note that your stock broker has to return the credit balance lying with them, within three working days in case you have not done any transaction within last 30 calendar days. Please note that in case of default of a Member, claim for funds and securities, without any transaction on the exchange will not be accepted by the relevant Committee of the Exchange as per the approved norms.

8. Check the frequency of accounts settlement opted for. If you have opted for running account, please ensure that your broker settles your account and, in any case, not later than once in 90 days (or 30 days if you have opted for 30 days settlement). In case of declaration of trading member as defaulter, the claims of clients against such defaulter member would be subject to norms for eligibility of claims for compensation from IPF to the clients of the defaulter member. These norms are available on Exchange website at following link :  https://www.nseindia.com/invest/about-defaulter-section.

9. Brokers are not permitted to accept transfer of securities as margin. Securities offered as margin/ collateral MUST remain in the account of the client and can be pledged to the broker only by way of ‘margin pledge’, created in the Depository system. Clients are not permitted to place any securities with the broker or associate of the broker or authorized person of the broker for any reason. Broker can take securities belonging to clients only for settlement of securities sold by the client. 10. Always keep your contact details viz. Mobile number/Email ID updated with the stock broker. Email and mobile number is mandatory and you must provide the same to your broker for updation in Exchange records. You must immediately take up the matter with Stock Broker/Exchange if you are not receiving the messages from Exchange/Depositories regularly.

11. Don't ignore any emails/SMSs received from the Exchange for trades done by you. Verify the same with the Contract notes/Statement of accounts received from your broker and report discrepancy, if any, to your broker in writing immediately and if the Stock Broker does not respond, please take this up with the Exchange/Depositories forthwith.

12. Check messages sent by Exchanges on a weekly basis regarding funds and securities balances reported by the trading member, compare it with the weekly statement of account sent by broker and immediately raise a concern to the exchange if you notice a discrepancy.

13. Please do not transfer funds, for the purposes of trading to anyone, including an authorized person or an associate of the broker, other than a SEBI registered Stock broker.”
.......... Issued in the interest of Investors"